 "markets, stock market, sensex, correction, nifty, shares, growth, profit, economy, gain")
On the back of strong domestic and international business, Lincoln Pharmaceuticals Limited posted a 23.44 per cent rise in its consolidated net profit for the third quarter ended December 31, 2020 at Rs 13.48 crore, from Rs 10.92 crore in the same quarter last year.
The drug maker's consolidated total revenue also grew by 13.70 per cent to Rs 115.47 crore in Q3 of FY 2020-21, from Rs 101.55 crore in Q3 of FY 2019-20.
According to Lincoln Pharma's managing director Mahendra Patel, the growth in revenue and profit came on the back of strong domestic and international business. The company posted
